Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

10.48
+0.29002.85%
Post-market: 10.490.0100+0.10%17:14 EDT
Volume:2.71M
Turnover:28.31M
Market Cap:1.91B
PE:-102.74
High:10.60
Open:10.15
Low:10.07
Close:10.19
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:1.04
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-196.29
PE(LYR):3,267.85

Loading ...

Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2020

Major Issues Report

8-K - Current report
Oct 08, 2020

Major Issues Report

8-K - Current report
Aug 20, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Jul 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 01, 2020

Major Issues Report

8-K - Current report
Jun 29, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 04, 2020

Major Issues Report

8-K - Current report